Xanax Patients Anxious Over 'Contamination' Recall

People who take the highly addictive anti-anxiety medication sold under the brand name Xanax have a new worry; contaminated medication.

Mylan Pharmaceuticals has issued a voluntary nationwide recall of a Alprazolam tablets (USP C-IV 0.5 mg, generic), in a lot distributed between July and August of this year, according to Newsweek.

The affected batch is lot number 8082708 and was sold in 500-pill bottles with an expiry date of September 2020. The recall has been issued on account of possible contamination with a foreign substance.

As of right now, the decision to recall sales of lot number 8082708 appears to be a precautionary action. According to a U.S. Food and Drug Administration (FDA) statement published Saturday, any adverse health effects relating to the batch have yet to be reported. -Newsweek

That said, "Clinical impact from the foreign material, if present, is expected to be rare, but the remote risk of infection to a patient cannot be ruled out," according to the company.

Anyone who has experienced medical issued they believe may have been caused by the drug is advised to speak with a medical professional, and can be reported to the FDA's MedWatch Adverse Event Reporting program.

A powerful benzodiazepine, Xanax works by targeting gamma-aminobutyric acid (GABA) receptors, making patients more relaxed and less anxious. It is incredibly easy to become addicted to the drug, and quitting cold turkey can result in life-threatening symptoms such as seizures.